4.5 Article

Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-κB

Pankaj K. Bhavsar et al.

FASEB JOURNAL (2008)

Article Cardiac & Cardiovascular Systems

Interactions between oxidative stress and inflammation in salt-sensitive hypertension

N. Tian et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Article Multidisciplinary Sciences

Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis

Norihiko Sakai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Pathology

Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury

Kengo Furuichi et al.

AMERICAN JOURNAL OF PATHOLOGY (2006)

Article Rheumatology

Up regulated expression of fractalkine/CX(3)CL1 and CX(3)CR1 in patients with systemic sclerosis

M Hasegawa et al.

ANNALS OF THE RHEUMATIC DISEASES (2005)

Article Urology & Nephrology

Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis

T Wada et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)

Article Pathology

Blockade of CCR2 ameliorates progressive fibrosis in kidney

K Kitagawa et al.

AMERICAN JOURNAL OF PATHOLOGY (2004)

Article Urology & Nephrology

High endothelial venule-like vessels in the interstitial lesions of human glomerulonephritis

M Takaeda et al.

AMERICAN JOURNAL OF NEPHROLOGY (2002)

Article Urology & Nephrology

Upregulation of fractalkine in human crescentic glomerulonephritis

K Furuichi et al.

NEPHRON (2001)